Document Classification

Section Type: RESULTS

Text: Improvement in the HOMAIR-score was observed with PIO and the combination, but not with SIMVA alone, which was accompanied by an increase in adiponectin with PIO treatment groups, but a decrease with SIMVA alone (baseline/endpoint : PIO : 14. 0 + / -8. 2 mg/l / 27. 6 + / - 14. 5 mg/l, p < 0. 05 ; PIO+SIMVA : 11. 7 + / -10. 0 mg/l/26. 7 + / -15. 7 mg/l, p < 0. 05 ; SIMVA : 15. 5 + / -12. 7 mg/l / 11. 6 + / -7. 0 mg/l, p < 0. 05).